Italia

27 nuovi farmaci in commercio

Nuove specialitą medicinali: Aybintio, Capaxyl, Duoperi, Jyseleca, Kirkos, Limnos, Rozetimad. 14 Nuovi farmaci equivalenti

Nuove specialità medicinali
AYBINTIO 1 flaconcino EV 100 mg 4 ml 25 mg/ml bevacizumab
SAMSUNG BIOEPIS NL B.V. AIC:048985016 511,21€ Cnn/OSP in commercio dal:25/01/2021

AYBINTIO 1 flaconcino EV 400 mg 16 ml 25 mg/ml bevacizumab
SAMSUNG BIOEPIS NL B.V. AIC:048985028 2047,43€ Cnn/OSP in commercio dal:25/01/2021

CAPAXYL 8 sacche EV 1.500 ml 100 mmol/L calcio cloruro diidrato
FRESENIUS MEDICAL CARE AIC:045983018 640,00€ Cnn/OSP in commercio dal:25/01/2021

DUOPERI 4 sacche EV 1.500 ml con elettroliti aminoacidi/elettroliti/glucosio (destrosio) anidro
FRESENIUS KABI AIC:048517054 420,00€ C /RNRL in commercio dal:15/03/2021

DUOPERI 4 sacche EV 2.000 ml con elettroliti aminoacidi/elettroliti/glucosio (destrosio) anidro
FRESENIUS KABI AIC:048517066 560,00€ C /RNRL in commercio dal:15/03/2021

JYSELECA 30 cpr riv 100 mg filgotinib
GILEAD SCIENCES AIC:049054012 1572,14€ Cnn/RNRL in commercio dal:01/02/2021

JYSELECA 30 cpr riv 200 mg filgotinib
GILEAD SCIENCES AIC:049054036 1572,14€ Cnn/RNRL in commercio dal:01/02/2021

KIRKOS 1 dispositivo vaginale 0,12 mg + 0,015 mg 24 ore etonogestrel/etinilestradiolo
FARMITALIA AIC:048049011 15,50€ Cnn/RR in commercio dal:08/02/2021

KIRKOS 3 dispositivi vaginali 0,12 mg + 0,015 mg 24 ore etonogestrel/etinilestradiolo
FARMITALIA AIC:048049023 38,00€ Cnn/RR in commercio dal:08/02/2021

LIMNOS 28 cps gastroresistenti 20 mg omeprazolo
C.T. LAB.FARMACEUTICO AIC:037942024 8,45€ A /RR in commercio dal:25/01/2021

ROZETIMAD 30 cpr 5 mg + 10 mg rosuvastatina sale di calcio/ezetimibe
ADAMED AIC:045424049 9,48€ A /RR in commercio dal:18/01/2021

ROZETIMAD 30 cpr 10 mg + 10 mg rosuvastatina sale di calcio/ezetimibe
ADAMED AIC:045424052 11,37€ A /RR in commercio dal:18/01/2021

ROZETIMAD 30 cpr 20 mg + 10 mg rosuvastatina sale di calcio/ezetimibe
ADAMED AIC:045424064 11,37€ A /RR in commercio dal:18/01/2021

Nuovi farmaci equivalenti
AMBRISENTAN TEVA 30 cpr riv 5 mg ambrisentan
TEVA B.V. AIC:047049061 2079,19€ A /RRL in commercio dal:21/01/2021

AMBRISENTAN TEVA 30 cpr riv 10 mg ambrisentan
TEVA B.V. AIC:047049147 2079,19€ A /RRL in commercio dal:21/01/2021

CASPOFUNGIN HIKMA 1 flaconcino polv conc soluz infus 70 mg caspofungin acetato
HIKMA AIC:044998021 513,75€ H /OSP in commercio dal:19/01/2021

CEFUROXIMA MYLAN 6 cpr riv 500 mg acetossietilcefuroxima
MYLAN AIC:048025062 5,60€ A /RR in commercio dal:21/01/2021

CINACALCET GEN.ORPH 28 cpr riv 30 mg cinacalcet cloridrato
GEN.ORPH AIC:046051025 142,32€ A /RRL in commercio dal:05/02/2021

CINACALCET GEN.ORPH 28 cpr riv 60 mg cinacalcet cloridrato
GEN.ORPH AIC:046051052 262,74€ A /RRL in commercio dal:05/02/2021

CINACALCET GEN.ORPH 28 cpr riv 90 mg cinacalcet cloridrato
GEN.ORPH AIC:046051088 394,13€ A /RRL in commercio dal:05/02/2021

COLECALCIFEROLO IPSO PHARMA orale soluz 2,5 ml 50.000 UI 1 contenitore monodose colecalciferolo
IPSO PHARMA AIC:043913058 6,90€ A /RR in commercio dal:25/01/2021

ENALAPRIL AUROBINDO PHARMA ITALIA 28 cpr 5 mg enalapril maleato
AUROBINDO AIC:046073084 3,09€ A /RR in commercio dal:19/01/2021

FLECAINIDE AUROBINDO 30 cpr 100 mg flecainide acetato
AUROBINDO AIC:042225033 8,54€ A /RR in commercio dal:25/01/2021

FULVESTRANT ACCORD 2 siringhe IM 5 ml 250 mg fulvestrant
ACCORD AIC:047437013 941,36€ H /RNRL in commercio dal:22/01/2021

GEMCITABINA AUROBINDO PHARMA ITALIA 1 flaconcino EV 200 mg gemcitabina cloridrato
AUROBINDO AIC:044078018 20,03€ H /OSP in commercio dal:20/01/2021

LEVETIRACETAM ALTAN 10 flaconcini EV 100 mg/ml 5 ml levetiracetam
ALTAN PHARMA LIMITED AIC:047546015 396,00€ Cnn/OSP in commercio dal:20/01/2021

VENLAFAXINA AUROBINDO 30 cps 150 mg rilascio prolungato venlafaxina cloridrato
AUROBINDO AIC:041691369 19,72€ A /RR in commercio dal:25/01/2021

SEZIONE DOWNLOAD